ABVITRO
At AbVitro, they are committed to advancing the treatment of poorly understood human diseases with an underlying immune component. Their mission is to harness the power of the human immune system and its role in complex diseases to uncover new potential therapeutic targets or biomarkers, while simultaneously discovering and evaluating their respective fully human antibody binders for therapeutic potential. Simply put, They find new therapeutic targets with matching therapeutic antibodies and/or T cell receptors (TCRs) in diseases with unmet medical needs.
ABVITRO
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.abvitro.com
Total Employee:
251+
Status:
Active
Contact:
3395451445
Email Addresses:
[email protected]
Total Funding:
1.87 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
ARase Therapeutics
Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
Sante Ventures
Sante Ventures investment in Series A - AbVitro
